SIDLEY AUSTIN LLP for COVIDIEN INC.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Educate federal agencies and congressional offices on the continuing need for specific nuclear reactors around the world to be available for the production of supplies of a radioactive material (molybdenum-99, or Mo-99) sufficient for Mallinckrodt (the pharmaceutical business of Covidien) to manufacture its Tc-99m generator medical-imaging radiopharmaceutical product
| Lobbyist | Covered position, as disclosed |
|---|---|
| PETER M GOODLOE New | Legislative Counsel, House Energy & Commerce ; ; Legislative Counsel, House Office of Legislative Counsel |
| WILLIAM A SARRAILLE New | N/A |
| ANDREW W SHOYER New | N/A |
Energy/Nuclear ENG
Educate federal agencies and congressional offices on the continuing need for specific nuclear reactors around the world to be available for the production of supplies of a radioactive material (molybdenum-99, or Mo-99) sufficient for Mallinckrodt (the pharmaceutical business of Covidien) to manufacture its Tc-99m generator medical-imaging radiopharmaceutical product
| Lobbyist | Covered position, as disclosed |
|---|---|
| PETER M GOODLOE New | Legislative Counsel, House Energy & Commerce ; ; Legislative Counsel, House Office of Legislative Counsel |
| WILLIAM A SARRAILLE New | N/A |
| ANDREW W SHOYER New | N/A |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| COVIDIEN PLC (ULTIMATE PARENT) | Ireland | Ireland | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.